Register to watch this on-demand, exclusive online session exploring King’s College London’s Global Medicines Development MSc. This prestigious, fully online programme equips you with the expertise to lead across the full lifecycle of modern medicines and accelerate your career.
What you’ll gain from this on-demand session:
Led by Programme Director Professor Jeremy Whitty, this recorded webinar offers a clear overview of the MSc and includes all content from the original live Q&A. Whether you’re already working in life sciences or related industries, or looking to enter these sectors, this on-demand session shows how the programme can support your ambitions.
Why watch:
- Learn how this MSc prepares you to meet the global demand for experts in developing safe, effective medicines
- See how flexible online learning fits seamlessly into your professional life
- Get an inside look at key modules and assessments that shape your learning journey
- Hear directly from the Programme Director through the recorded Q&A
Why study the Global Medicines Development MSc at King’s?
- We’re ranked 11th in the world for Life Sciences & Medicine (QS World University Rankings by Subject 2025).
- King's’ Centre for Pharmaceutical Medicine Research is a PharmaTrain Centre for Excellence. This reflects the rigorous, industry-relevant education you’ll receive.
- We’re partnered with leading NHS medical institutions including Guy’s, King’s College and St Thomas’ Hospitals.
Professor Jeremy Whitty
Programme Director
MSc in Global Medicines Development
Professor Jeremy Whitty is the Programme Director of the online MSc in Global Medicines Development and he is responsible for the design, development, and delivery of the programme. His work focuses on equipping students with the scientific and leadership skills needed to navigate the complexities of global medicines development.
He is also supporting the development of the Global Medicines Development Network, an initiative founded by the Centre for Pharmaceutical Medicine Research at King’s. The network will transform global drug development by building equitable and sustainable educational and research capacity worldwide, connecting universities, industry, and policy-makers and help improve access to innovative medicines for all.
Professor Whitty has 30 years’ experience working in academia and the pharmaceutical industry and he has held academic positions at institutions such as Karolinska Institutet, the University of the Western Cape, Oxford University and IE Business School in Madrid.
With industry experience in vaccines, biologics and medical devices his expertise spans pharmaceutical science and technology, clinical operations, regulatory science and more recently, the commercialisation of Advanced Therapy Medicinal Products (ATMPs).
Professor Whitty's research addresses critical challenges in the commercialisation of Advanced Therapy Medicinal Products (ATMPs), exploring innovative strategies to improve decision-making processes. Inspired by public-private partnership models developed during COVID-19 vaccine initiatives, his research emphasises early engagement with Health Technology Assessment (HTA) bodies and healthcare payers.